Tiziana Life Sciences (TLSA) announced that its Chief Executive Officer, Ivor Elrifi, has purchased 14,848 shares of Tiziana common stock at a price of $1.65 per share in the open market, correcting today’s earlier press release. This brings his current purchased shares total to 193,848, the company stated.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences CEO Buys Shares, Signaling Confidence in Innovative Therapies
- Tiziana Life Sciences announces purchase of shares by CEO
- Tiziana Life Sciences Chairman Increases Stake with Recent Share Purchase
- Tiziana Life Sciences announces purchase of shares by chairman
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab